Biocon Announces Publication of Phase III Clinical Data Supporting Yesafili™ (Aflibercept Biosimilar) 09/07/2026 / Regulatory Filings / Clinical Trial / Product Development Biocon Announces Publication of Phase III Clinical Data Supporting Yesafili™ (Aflibercept Biosimilar) Read Post »
